Molnupiravir

Norma icmr junk oral antivirus, antibiotics

Mumbai: Oral antivirus, antibiotics, monoclonal antibodies and vitamins have no place in the latest Indian Covid management guidelines, which are…

3 years ago

Maharashtra plans the norm to curb the use of rampant monoclonal antibodies

(By Umesh Ishalkar) The use of the makers of monoclonal antibodies in Covid patients has encouraged the country to frame…

3 years ago

There is no antivirus, antibacterial if covid is light: experts

Pune: When all guidelines suggest the use of antibacterial and antibacterials that are careful of Covid, experts, including those from…

3 years ago

Maha plans the norm to curb the use of rampant monoclonal antibodies

(By Umesh Ishalkar) The use of the makers of monoclonal antibodies in Covid patients has encouraged the country to frame…

3 years ago

Molnupiravir is not many benefits, will not save it in the protocol, the ICMR task unit said

The ICMR national task force for Covid-19 has decided to include Molnupiravir antivirus drugs in the clinical management protocol for…

3 years ago

IIT modeling shows Covid cases will rise quickly in the coming days, government experts said

New Delhi: A government health expert on Tuesday said that IIT modeling has shown Covid cases will increase rapidly in…

3 years ago

Molnupiravir is not included in the Covid-19 clinical management protocol like now

New Delhi: ICMR National Task Force for Covid-19 has decided to oppose the Molnupiravir antivirus drug in the clinical management…

3 years ago

Experts are divided into the use of molnupiravir; low drug request

Nagpur: Experts in Covid treatment have various opinions about the use of Molnupiravir anti-virus drugs on which the Indian Medical…

3 years ago

Molnupiravir gets an overweigh risk: ICMR counter expert

Hyderabad: Members of the leading Covid-19 task task and health experts who treat patients Coronavirus throughout the country said on…

3 years ago

Panel to take covid pill approval today

New Delhi: Animal Regulator Subject Expert Committee (SEC) will check the application on Thursday looking for marketing authorization for Molnupiravir,…

3 years ago